STTK
Shattuck Labs, Inc.Company Information
- Company Name
- Shattuck Labs, Inc.
- CIK
- CIK0001680367
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- STTK: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- STTK
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-09
- Last sale
- 2026-07-02
- Shares purchased (TTM)
- 12,674,754
- Shares sold (TTM)
- 62,542
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 67,513,774
- Shares outstanding
- 129,779,297
- Ownership
- 52.02%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- -5.43%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 63 | 90 | 54 | 43 | 50 | 61 | 57 | 44 | 61 | 76 | 126 | 41 | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Current | 145 | 0 | 24 | 44 | 0 | 0 | 16 | 46 | 45 | 39 | 5 | 60 | ||||||
| Prepaid Expense And Other Assets Current | 5 | 3 | 4 | 5 | 4 | 6 | 6 | 9 | 9 | 16 | 13 | 12 | ||||||
| Assets Current | 213 | 94 | 82 | 91 | 55 | 66 | 79 | 99 | 114 | 131 | 143 | 113 | ||||||
| Property Plant And Equipment Net | 5 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Noncurrent | 1 | 1 | 1 | - | - | - | 0 | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 2 | 2 | 1 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | ||||||
| Assets | 221 | 102 | 91 | 100 | 64 | 77 | 91 | 112 | 129 | 146 | 160 | 130 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 4 | 1 | 2 | 1 | 0 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | ||||||
| Contract With Customer Liability Current | - | - | - | - | - | - | - | - | 3 | 5 | - | - | ||||||
| Liabilities Current | 8 | 4 | 7 | 5 | 5 | 7 | 9 | 12 | 15 | 14 | 11 | 14 | ||||||
| Operating Lease Liability Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | ||||||
| Liabilities | 10 | 6 | 9 | 7 | 7 | 10 | 11 | 15 | 18 | 18 | 15 | 18 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 672 | 541 | 513 | 511 | 465 | 463 | 461 | 460 | 457 | 454 | 451 | 401 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -460 | -445 | -431 | -418 | -408 | -395 | -382 | -363 | -346 | -325 | -306 | -289 | ||||||
| Stockholders Equity | 211 | 96 | 82 | 93 | 57 | 68 | 80 | 97 | 111 | 129 | 145 | 113 | ||||||
| Liabilities And Stockholders Equity | 221 | 102 | 91 | 100 | 64 | 77 | 91 | 112 | 129 | 146 | 160 | 130 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 101 | 76 | 63 | 63 | 48 | 48 | 48 | 48 | 48 | 48 | 47 | 42 | ||||||
| Shares Outstanding | 101 | 76 | 63 | 63 | 48 | 48 | 48 | 48 | 48 | 48 | 47 | 42 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialShattuck Labs, Inc. (STTK) — SEC Financial Statements & Analysis
Shattuck Labs, Inc. (STTK) is a pharmaceutical preparations company, incorporated in DE. Shattuck Labs, Inc. trades on Nasdaq as: STTK. Shattuck Labs, Inc. (STTK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, Shattuck Labs, Inc. carries a market cap of $900.67M, a P/E ratio of -17.13x, a P/B ratio of 4.27x, a P/S ratio of 900.67x, an enterprise value of $837.37M, and an EV/EBITDA multiple of -16.05x. On profitability, it posts an operating margin of -5578.70%, a net margin of -5256.80%, a Return on Equity (ROE) of -39.21%, a Return on Assets (ROA) of -36.88%, and a Return on Invested Capital (ROIC) of -72.23%. Per share, it reports EPS of $-0.41, diluted EPS of $-0.41, free cash flow per share of $-0.32, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -66.63% year-over-year, net income growth of -14.54% year-over-year, and EPS growth of -66.42% year-over-year. On the balance sheet, it maintains a current ratio of 27.59x, a quick ratio of 26.94x, working capital of $205.54M, a debt-to-equity ratio of 0.05x, a debt ratio of 0.04, free cash flow of $-41.24M (TTM), and net debt of $-63.30M. Figures sourced from SEC EDGAR.
- Market Cap
- $900.67M
- P/E TTM
- -17.13x
- EPS TTM
- $-0.41
- P/B TTM
- 4.27x
- ROE TTM
- -39.21%
- ROA TTM
- -36.88%
- Debt To Equity
- 0.05x
- Free Cash Flow TTM
- $-41.24M
- Net Revenue TTM Growth 1Y
- -66.63%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Shattuck Labs, Inc. in?
Shattuck Labs, Inc. (STTK) operates in the Pharmaceutical Preparations industry.
What exchange does STTK trade on?
Shattuck Labs, Inc. (STTK) trades on the Nasdaq.
Where is Shattuck Labs, Inc. incorporated?
Shattuck Labs, Inc. is incorporated in DE.
When was Shattuck Labs, Inc. (STTK)'s most recent SEC filing?
Shattuck Labs, Inc. (STTK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is STTK's market cap?
Shattuck Labs, Inc. (STTK) has a market capitalization of $900.67M as of 2026-06-30.
What is STTK's EPS (earnings per share)?
Shattuck Labs, Inc. (STTK)'s trailing twelve month EPS is $-0.41 as of 2026-06-30.
What is STTK's ROE (return on equity)?
Shattuck Labs, Inc. (STTK)'s trailing twelve month Return on Equity (ROE) is -39.21% as of 2026-06-30.
What is STTK's ROA (return on assets)?
Shattuck Labs, Inc. (STTK)'s trailing twelve month Return on Assets (ROA) is -36.88% as of 2026-06-30.
What is STTK's ROIC (return on invested capital)?
Shattuck Labs, Inc. (STTK)'s trailing twelve month Return on Invested Capital (ROIC) is -72.23% as of 2026-06-30.
What is STTK's EV/EBITDA?
Shattuck Labs, Inc. (STTK)'s trailing twelve month EV/EBITDA is -16.05x as of 2026-06-30.